Trumble Troy N
Department of Large Animal Clinical Sciences, University of Florida, College of Veterinary Medicine, PO Box 100136, Gainesville, FL 32610, USA.
Vet Clin North Am Equine Pract. 2005 Dec;21(3):575-97, v-vi. doi: 10.1016/j.cveq.2005.08.004.
In horses, lameness is often attributable to some degree of osteoarthritis (OA), a complex disease process that is highlighted by eventual degradation of articular cartilage. Conventional therapies for OA in horses are designed to relieve pain and discomfort and often include pharmacologic intervention with nonsteroidal anti-inflammatory drugs or intra-articular steroids. Oral administration of nutraceutical products to the horse is common and easy and is perceived to be a benign treatment for OA in horses. The main goal for use of nutraceuticals is to use them in OA cases to attempt to lower the dose of other drugs that are more problematic while potentially preventing further degradation (disease or structure modifying). This article attempts to define a nutraceutical, identifies areas that need to be considered when these products are used, and describes the known scientific effects of the most common compounds contained in currently available equine nutraceuticals.
在马匹中，跛行往往在一定程度上归因于骨关节炎（OA），这是一种复杂的疾病过程，最终会导致关节软骨退化。马匹OA的传统疗法旨在缓解疼痛和不适，通常包括使用非甾体抗炎药或关节内注射类固醇进行药物干预。给马匹口服营养保健品很常见且容易操作，并且被认为是治疗马匹OA的一种良性方法。使用营养保健品的主要目的是在OA病例中使用它们，试图降低其他更具问题的药物的剂量，同时有可能防止进一步退化（疾病或结构改善）。本文试图定义一种营养保健品，确定使用这些产品时需要考虑的领域，并描述目前可用的马用营养保健品中最常见化合物的已知科学作用。
